INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,704 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FA
Fleitas ArmandoEVP, Chief Accounting Officer
AMTBAmerant Bancorp Inc.
Grant or award
A—
1,093 sh
Jun 8, 2026Jun 10, 2026
Page 686 of 1718
← PrevNext →
traded Jun 8, 2026
+2d
SEC Form 4

Evidence

9
YR
Yeates Darren RonaldEVP & COO
BTUPEABODY ENERGY CORP
Grant or award
A$3,411
121 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
IS
Innocenzi StefanosSVP, Linde Engineering
LINLINDE PLC
Option exercise
M—
4,035 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
CS
Cohn SpencerDirector
FSUNFIRSTSUN CAPITAL BANCORP
Grant or award
A—
2,099 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
FB
Fore Thomas ButlerDirector
SBEVSPLASH BEVERAGE GROUP, INC.
Grant or award
A—
500.0K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
VP
Volent PaulaDirector
DIBS1stdibs.com, Inc.
Option exercise
M—
40.9K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
11.5K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
WC
Whitman Margaret CDirector
CRWVCoreWeave, Inc.
Grant or award
A—
2,532 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
AJ
Annas Christopher J.Director, Chairman & CEO
MRBKMeridian Corp
Option exercise
M—
42.0K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
HR
Hohman RobertDirector
NXDRNextdoor Holdings, Inc.
Option exercise
M—
106.7K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
HR
Harris Keith R.Director
MGTXMeiraGTx Holdings plc
Option exercise
M—
75.0K sh
Jun 10, 2026Jun 10, 2026
traded Jun 10, 2026
+0dSEC Form 4

Evidence

9
CW
Caple Frederick WilliamDirector
SBEVSPLASH BEVERAGE GROUP, INC.
Grant or award
A—
500.0K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$6,852
936 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
HH
Hutchins Glenn HDirector
CRWVCoreWeave, Inc.
Grant or award
A—
2,532 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
ML
Maxwell LindaDirector
IBRXImmunityBio, Inc.
Grant or award
A—
65.6K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

9
TK
Talluri Rajendra KDirector, President and CEO
ENVXEnovix Corp
Tax withholding
F$31K
4,301 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

9
MA
McKnight Andrew A.Director
MPMP Materials Corp. / DE
Grant or award
A—
3,038 sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

9
TP
Tipirneni Praveen P.Director
TECXTectonic Therapeutic, Inc.
Grant or award
A—
10.2K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

9
GC
Glessner ColeenEVP, Quality & Ethics, and CPL
EBSEmergent BioSolutions Inc.
Tax withholding
F$16K
2,018 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
123 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
BE
Baratz Alan EDirector, President & CEO
QBTSD-Wave Quantum Inc.
Option exercise
M$180K
213.2K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
Silbermann BenjaminDirector, 10% Owner
PINSPINTEREST, INC.
Derivative conversion · 10b5-1 plan
C$1.02M
46.9K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

8
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5,654
57 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
OK
Oreshack KurtGeneral Counsel
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$127K
25.0K sh
Jun 10, 2026Jun 10, 2026
traded Jun 10, 2026
+0dSEC Form 4

Evidence

8
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4,799
48 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
223 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2,937
29 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

8
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2,076
20 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

7
AO
Atay OguzhanDirector, See Remarks
BLLNBillionToOne, Inc.
Option exercise · 10b5-1 plan
M$18K
6,250 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

7
CA
Cannestra AnthonyDirector
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

6
JH
Jayabalan HarishEVP, CISO and CRO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise · 10b5-1 plan
M$123K
10.2K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

5
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
10.0K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC Form 4

Evidence

5
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Gift
G—
52.1K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Gift
G—
52.1K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Gift
G—
52.1K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
24.5K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Gift
G—
52.1K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Gift
G—
52.1K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Gift
G—
52.1K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence

5
SC
Selecky ChristobelDirector
IBRXImmunityBio, Inc.
Grant or award
A—
65.6K sh
Jun 9, 2026Jun 10, 2026
traded Jun 9, 2026
+1dSEC Form 4

Evidence